" /> Rhabdoid tumor predisposition syndrome 1 - CISMeF





Preferred Label : Rhabdoid tumor predisposition syndrome 1;

Symbol : RTPS1;

CISMeF acronym : RDT; RTPS1;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Brain tumor, posterior fossa, of infancy, familial;

Included titles and symbols : Malignant rhabdoid tumor, somatic; Rhabdoid tumor; Teratoid tumor, atypical; At/rt; RDT;

Description : The rhabdoid tumor predisposition syndrome is an autosomal dominant cancer syndrome predisposing to renal or extrarenal malignant rhabdoid tumors and to a variety of tumors of the central nervous system, including choroid plexus carcinoma, medulloblastoma, and central primitive neuroectodermal tumors (Sevenet et al., 1999). Rhabdoid tumors are a highly malignant group of neoplasms that usually occur in children less than 2 years of age. Malignant rhabdoid tumors (MRTs) of the kidney were first described as a sarcomatous variant of Wilms tumors (Beckwith and Palmer, 1978). Later, extrarenal rhabdoid tumor was reported in numerous locations, including the central nervous system (CNS) (Parham et al., 1994). Classification has been difficult because of considerable variation in the histologic and immunologic characteristics within and between rhabdoid tumors of the liver, soft tissues, and CNS. In the CNS, rhabdoid tumors may be pure rhabdoid tumors or a variant that has been designated atypical teratoid tumor (AT/RT).;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily B, member 1 gene (SMARCB1, 601607.0001);

Neoplasia : Rhabdoid tumors, malignant (renal or extrarenal); Atypical teratoid tumors; Choroid plexus carcinoma; Medulloblastoma;

Prefixed ID : #609322;

Details


You can consult :


Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.